Podcasts about Phase

On this episode of Longevity by Design, Dr. Gil Blander sits down with Dr. Karl Pfleger, aging biotechnology investor and creator of AgingBiotech.info, to dissect the rapidly evolving field of aging therapeutics. Karl breaks down the sector into two main categories: interventions that slow aging rates versus rejuvenation strategies that repair accumulated damage.Karl highlights the most promising areas in his investment portfolio, including senolytics for clearing senescent cells and epigenetic reprogramming technologies. He explains why current aging clocks aren't ready for clinical use and discusses the limitations of popular interventions like GLP-1 drugs and fasting protocols. The conversation reveals that 14 Phase 3 clinical trials are currently testing core aging therapeutics.The discussion covers recent FDA approvals for ATTR treatments and stem cell therapies, signaling the field's maturation. Karl emphasizes that meaningful life extension requires a "divide and conquer" strategy, targeting multiple aging mechanisms simultaneously rather than relying on single interventions. Despite exciting therapeutic developments, he maintains that optimizing diet, exercise, and sleep remains the most impactful strategy for extending healthspan today.Guest-at-a-Glance

We would love to pray for you! Please send us your request here. --------Thank you for listening! Your support of Joni and Friends helps make this show possible. Joni and Friends envisions a world where every person with a disability finds hope, dignity, and their place in the body of Christ. Become part of the global movement today at www.joniandfriends.org. Find more encouragement on Instagram, TikTok, Facebook, and YouTube.

​If you're ready to take your emotional growth to the next level, join the EQ Mafia at https://www.eqgangster.com/. Follow us at: https://www.arrowhead-leadership.com

That's a wrap on the MCU's Phase 5! Join Jeff, Steve, and John as they look back on the movies and TV shows that worked best, and, well, perhaps not so best in this latest chapter of the Marvel Cinematic Universe!

As retirement plan participants transition from the accumulation phase to decumulation, the focus moves from building wealth to ensuring sustainable income—what's also known as "value creation."Danielle Kelso, Senior Institutional Solutions Consultant at Allianz Life Insurance Company of North America, joins the 401(k) Specialist Pod(k)ast to shed light on the changes and innovations shaping the future of retirement security. In her role, Kelso provides research, analytics and product expertise to the Allianz sales team, and shares her expertise on what retirement plan advisors and plan sponsors need to be thinking about when it comes to supporting a retiree's lifestyle by ensuring stable income and managing risks effectively.Key Insights:Personalized Income Planning Replaces One-Size-Fits-AllThe future of retirement planning lies in personalized strategies. Custom plans that integrate all income sources and reflect individual goals and spending habits offer better outcomes than generic investment approaches.Redefining Value Creation in RetirementValue creation is evolving beyond accumulating the highest portfolio balance. In retirement, it now centers on generating reliable, sustainable income that supports lifestyle and essential needs. This shift emphasizes peace of mind and financial security over raw returns.Annuities Play a Key Role in Managing Retirement RisksModern annuities help mitigate key retirement risks such as longevity, market volatility, inflation, and personal life changes. Allianz research shows that portfolios including annuities significantly improve the probability of meeting income goals—by up to 25–40% in adverse markets.See Also:Exploring Guaranteed Income in DC Plan Trends with Allianz Life's Matt StubblefieldSolving the Portability Puzzle with Allianz Life's Ben ThomasonExploring Retirement Income Strategies with Joshua Grass and Todd Levy

Do they have no shame? Budge and Matt absorb some of the most turgid guitar news this week on the Fret Talk Podcast. For as little as $2 you can be part of the exclusive patreoncrew, just visit www.patreon.com/frettlakCheck out oursponsor at www.affordaboard.co.uk for some of the coolest affordablepedals at great prices. Offering brands such as Caline, 4D, Mosky,DemonFX, JSA Effects and Joyo, all ready to ship with free shippingto the UK (international shipping available too, just message for aquote).Don't forget tohave your online on the Fret Talk Podcast group on Facebookhttps://www.facebook.com/groups/690366661155328/?ref=bookmarkssayand join in withthe live streams at the PBOD Grouphttps://www.facebook.com/groups/64533347864/Find your hostat:BudgetPedalChapwww.Facebook.com/budgetpedalchapwww.Instagram.com/budgetpedalchaphttps://www.youtube.com/budgetpedalchapor search ‘budgetpedal chap' on YouTubeMattwww.Facebook.com/SwitchIOMwww.twitch.tv/heel_mattqwww.twitter.com/heel_mattqwww.instagram.com/heel_mattqLeehttps://www.facebook.com/groups/64533347864/www.pbodoom.comwww.youtube.com/pedalboardsofdoomJoshwww.instagram.com/thecoronamortisWillhttp://www.arocketcomplex.com/www.youtube.com/user/ARocketComplexwww.instagram.com/arcwillpowell/Olliewww.Facebook.com/OllieMilesMusic

Herzlich willkommen zu einer neuen Folge des mosaik Podcast. Die heutige Ausgabe ist Teil der Kooperation zwischen mosaik und der Zeitschrift PROKLA, in deren Rahmen wir bereits  zwei Folgen veröffentlicht haben. Zum einen das Interview mit Dorothea Schmidt über die Geschichte und Entwicklung der PROKLA, zum anderen das Gespräch mit Tine Haubner und Jakob Graf über über das Heft „Surplus Society – ‚Überflüssige‘ im Gegenwartskapitalismus“, das die beiden mitherausgegeben haben. Nun ist eine neue Ausgabe der PROKLA erschienen. Aus diesem Grund habe ich Anfang Juli Ruben Kaiser und Markus Wissen getroffen, die an der Herausgabe des Hefts mitgewirkt haben. Die inhaltliche Klammer des Hefts bildet das Thema „Sozial-ökologische Bewegungen im Spannungsfeld von Staat und Demokratie“. Worum geht es also? Die sozial-ökologische Krise spitzt sich zu. Der Klimawandel und die Zerstörung ökologischer Lebensgrundlagen schreiten ungebrochen voran. Obwohl es in dieser Situation dringender denn je gesellschaftliche Kräfte bräuchte, die die Krise wirksam politisieren, befinden sich sozial-ökologische Bewegungen selbst in einer Krise. Die gegenwärtige Phase ist sowohl durch Repression und politische Rückschläge gekennzeichnet als auch durch eine notwendige strategische Neuausrichtung. In der Auseinandersetzung mit Staat und Demokratie können sozial-ökologische Bewegungen neue politische Horizonte eröffnen – vorausgesetzt, sie begreifen ihre Kämpfe nicht nur als ökologische oder moralische, sondern als zutiefst politische und soziale.

Mon, 21 Jul 2025 17:03:00 +0000 https://jungeanleger.podigee.io/2431-kapitalmarkt-stimme-at-daily-voice-202-365-osterreichische-schule-in-die-osterreichischen-schulen-javier-milei-und-borse bc354986ea3dc0a72944fcbc86eb48c2 Episode 202/365 der kapitalmarkt-stimme.at daily voice auf audio-cd.at. Ich bin Österreicher und die Österreichische Schule kennt in Österreich leider so gut wie niemand. In den Österreichischen Schulen selbst wohl die wenigsten Lehrer und damit die Schüler schon gar nicht. Wohl auch bewusst nicht, denn Freiheit und Staat, das verträgt sich nicht immer. Es ist dem irritierenden, aber auch faszinierenden, Argentinier Javier Milei zu verdanken, dass Hayek und von Mises gerade ein Comeback in der Wahrnehmung erhalten. Wir kennen das deutsche Wirtschaftswunder nach dem Krieg und erleben jetzt eine Phase, die in D und A nicht unwahrscheinlich als negatives Wirtschaftswunder in die Geschichte eingehen wird. Der Staat hat es übertrieben und sehr viel zerstört. Und deswegen ist es wichtig, Hayek, Mises und deren Promoter Milei zumindest zu kennen und im Hinterkopf zu haben. Um mitreden zu können und vielleicht ein sanftes Umdenken einzuleiten. Es muss ja nicht mit soviel Carajo wie in Argentinien erfolgen. Es wäre Zeit für ein Wirtschaftswunder, da ist die Österreichische Schule eine Zutat. Und die Börse würde sich freuen. https://austrian-institute.org/de/oesterreichische-schule/ Die Ära Milei: https://www.audible.de/pd/Die-Aera-Milei-Hoerbuch/B0DTZ2VNLW https://www.youtube.com/@MILEIPRESIDENTE Unser Ziel: Kapitalmarkt is coming home. Täglich zwischen 19 und 20 Uhr. kapitalmarkt-stimme.at daily voice Playlist auf spotify: http://www.kapitalmarkt-stimme.at/spotify http://www.kapitalmarkt-stimme.at Musik: Steve Kalen: https://open.spotify.com/artist/6uemLvflstP1ZerGCdJ7YU Playlist 30x30 (min.) Finanzwissen pur: http://www.audio-cd.at/30x30 Bewertungen bei Apple (oder auch Spotify) machen mir Freude: http://www.audio-cd.at/apple http://www.audio-cd.at/spotify 2431 full no Christian Drastil Comm.

Tonix Pharmaceuticals Holdings CEO Dr Seth Lederman joined Steve Darling from Proactive to discuss updates on two of the company's key investigational therapies: TNX-801 and TNX-102 SL. Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Lederman shared recent findings on TNX-801, a recombinant horsepox-derived live-virus vaccine candidate for mpox and smallpox presented at the Vaccine Congress 2025 in Vienna. The latest data demonstrate that TNX-801 delivers durable humoral and cellular immunity from a single dose, while remaining highly attenuated—replicating much times less than licensed vaccinia strains in primary human dermal cells. In interferon receptor knockout mice, it was shown to be up to 100,000-fold less virulent than legacy vaccines. The company announced that subcutaneous (s.c.) administration provides equivalent protection to the traditional percutaneous method. This finding supports a development shift toward the s.c. format, aligning TNX-801 with standard administration routes for most live-virus vaccines. Potential benefits include reduced risk of scarring, bacterial superinfection, and inadvertent transfer of vaccine to other parts of the body—challenges associated with percutaneous delivery. In addition to the vaccine data, Lederman also shared the update that a peer-reviewed manuscript has recently published on-line in the journal Pain Medicine describing the Phase 3 RESILIENT trial of TNX-102 SL, a centrally acting, non-opioid analgesic for fibromyalgia pain. The randomized, double-blind, placebo-controlled Phase 3 study enrolled 457 patients across 33 U.S. sites. Participants received a stepped dose of TNX-102 SL, beginning at 2.8 mg for two weeks and escalating to 5.6 mg for twelve weeks. TNX-102 SL was well tolerated, with the most common side effects being mild and transient oral sensations. No drug-related serious adverse events or deaths were reported. These updates reinforce Tonix's strategic focus on unmet medical needs across infectious disease and chronic pain indications. TNX-801's next-gen vaccine and TNX-102 SL's non-opioid analgesic for fibromyalgia relief position the company as a leader in advancing novel vaccines and therapeutics #proactiveinvestors #tonixpharmaceuticalsholdingcorp #nasdaq #tnxp #Biotech #MPOXVaccine #Smallpox #TNX801 #VaccineDevelopment #ClinicalTrials #PharmaceuticalNews #MedicalResearch #WHO #GlobalHealth #InfectiousDiseases #Biopharma #ProactiveInvestors #tnx-102sl

The final phase of London's Mobility Master Plan with Ward 7 Councillor Corrine Rahman.

Welcome to HCPLive's 5 Stories in Under 5—your quick, must-know recap of the top 5 healthcare stories from the past week, all in under 5 minutes. Stay informed, stay ahead, and let's dive into the latest updates impacting clinicians and healthcare providers like you! Interested in a more traditional, text rundown? Check out the HCPFive! Top 5 Healthcare Headlines for July 7-13, 2025: FDA Approves Finerenone (Kerendia) for Heart Failure with Ejection Fraction of 40% or More Finerenone (Kerendia) was approved on July 14, 2025, to reduce cardiovascular death and heart failure hospitalizations in adults with HFmrEF or HFpEF, based on data from the FINEARTS-HF trial. Baxdrostat Meets Efficacy Endpoint in Phase 3 Trial for Resistant Hypertension In the phase 3 BaxHTN trial, baxdrostat significantly reduced systolic blood pressure in patients with resistant hypertension, supporting its potential as a first-in-class aldosterone synthase inhibitor. FDA Approves Updated VARIPULSE Platform Irrigation Flow Rate for Heart Disease The FDA approved an updated irrigation flow rate for the VARIPULSE Platform, which has been used in over 10,000 procedures with a reported neurovascular adverse event rate of less than 0.5%. Palopegteriparatide Provides Sustained Response in Adults with Hypoparathyroidism Palopegteriparatide showed durable 3-year improvements in biochemistries, kidney function, and quality of life across all forms of hypoparathyroidism in the phase 3 PaTHway trial. FDA Grants Orphan Drug Designation to Taladegib, Potential Idiopathic Pulmonary Fibrosis Treatment Taladegib received Orphan Drug Designation on July 16, 2025, as a potential treatment for idiopathic pulmonary fibrosis, currently being studied in the phase 2b WHISTLE-PF trial.

Listen to the top News of 20/07/2025 from Australia in Hindi.

Ref.: Pfr. Leo Tanner, Exerzitienleiter Mitinitiator Wege erwachsenen Glaubens (WEG), Jonschwil (Kantons St. Gallen, Schweiz Heilung der Lebensgeschichte Unsere Seelenwunden Gott anvertrauen - inneren Frieden finden Niemand kommt ohne Beulen und blaue Flecken an der Seele durchs Leben. Weil die Menschen um uns herum nicht perfekt sind und uns das Leben auch belastende Erfahrungen zumutet, finden sich in unserem Innern Spuren alter Verletzungen. Oft spüren wir sie nicht direkt, sondern zum Beispiel an eingefahrenen Verhaltensmustern, die wir weder ganz zuordnen noch abschütteln können. Diesen verborgenen Wunden versuchen wir in der Lebenshilfe auf die Spur zu kommen. In der Reihe „Frieden finden durch Heilung der Lebensgeschichte betrachtet der erfahrene Exerzitien-Prediger Leo Tanner acht Lebensphasen. Immer wird zuerst Gottes Sicht und Plan für unser Leben dargestellt, dann wird auf mögliche Wunden und ihre Wurzeln hingewiesen. Fragen zur Reflexion helfen, in die eigene Lebensgeschichte zurückzugehen. Dann werden heilende Wege aufgezeigt. Heute geht es in der sechsten Phase um das frühe Erwachsenenalter. Zu jeder Phase gibt es Heilungsgebete, die Sie von unserer Homepage herunter laden können, aber auch auf der Seite von Pfarrer Leo Tanner www.leotanner.ch finden.

Wanna start a side hustle but need an idea? Check out our Side Hustle Ideas Database: https://clickhubspot.com/thds We're breaking down the wild contradictions in AI land, where companies are simultaneously laying off workers and throwing billions at acquisitions, plus Google's new feature that lets AI make your awkward phone calls to local businesses. Plus: South Korea is booming with startups and Pepsico beats Wall Street earnings expectations. Join our hosts Jon Weigell and Maria Gharib as they take you through our most interesting stories of the day. Follow us on social media: TikTok: https://www.tiktok.com/@thehustle.co Instagram: https://www.instagram.com/thehustledaily/ Thank You For Listening to The Hustle Daily Show. Don't forget to hit subscribe or follow us on your favorite podcast player, so you never miss an episode! If you want this news delivered to your inbox, join millions of others and sign up for The Hustle Daily newsletter, here: https://thehustle.co/email/  If you are a fan of the show be sure to leave us a 5-Star Review, and share your favorite episodes with your friends, clients, and colleagues.

Carbs are not bad, but some just don't do you any favors when your goal is fat loss. In this episode, I'm breaking down the 3 types of carbohydrates I personally avoid when I'm trying to lose body fat. These carbs won't keep you full, won't fuel your consistency, and honestly… they make fat loss way harder than it needs to be. I'll break down what they are, why they matter, and what types of carbs to have instead. Get 10% off MY FAVORITE gut health supplements that I have been using for 2+ years!Do you feel like your metabolism has slowed down? Get my FREE course to truly learn how your body works so you can see long term success. Enroll here.Shop my FAVE things HEREWant access to exclusive content? Sign up for my newsletter here!

Strap in, truth warriors—@intheMatrixxx and @shadygrooove, the unyielding duo dismantling deep-state deceptions, charge into Season 7, Episode 135, “Epstein ‘Scam' Perpetuated By Dems Update; Pandora's Box Trusts & Trustees,” airing live on July 18, 2025, at 12:05 PM Eastern! They kick off by exposing Epstein Binder Gate's Phase 1, revealing key players in the orchestrated chaos, as President Trump blasts the Wall Street Journal for "stepping in it" with a fabricated 2003 birthday letter story, threatening to sue the outlet and its owner for pushing this Democrat-fueled hoax. Jeff and Shannon highlight Trump's directive to AG Pam Bondi to seek court approval for unsealing grand jury testimonies, delivering on the "release the files" demand and countering the Justice Department's stonewalling amid MAGA demands for transparency.washingtonpost.com Shifting to explosive intel, they break down a Promethean Action video exposing the Epstein psyop, featuring insights from Steve Bannon and Tucker Carlson on foreign intelligence ties and calls for a special prosecutor to unravel the narrative's true agenda.youtube.comyoutube.com In the Rumble Premium hour, the Pandora's Box read presses on, delving into trusts and trustees that transformed everything into property of the shadowy 'company,' linking back to elite financial webs shielding the powerful. With live chat BOOMs, razor-sharp analysis, and a community firing on all cylinders, the MG Show challenges MSM lies and fake MAGA distractions. The truth is learned, never told—arm yourself with the constitution as your weapon and tune in at noon-0-five Eastern LIVE to stand with Trump! Keywords Trump, Epstein Binder Gate, WSJ hoax, AG Bondi unsealing, grand jury testimonies, Promethean Action, Epstein psyop, Bannon, Carlson, Pandora's Box, trusts, trustees, America First, MG Show, @intheMatrixxx, @shadygrooove, transparency, New World Order Tune in weekdays at 12pm ET / 9am PST, hosted by @InTheMatrixxx and @Shadygrooove. Catch up on-demand on https://rumble.com/mgshow or via your favorite podcast platform. Where to Watch & Listen Live on https://rumble.com/mgshow https://mgshow.link/redstate X: https://x.com/inthematrixxx Backup: https://kick.com/mgshow PODCASTS: Available on PodBean, Apple, Pandora, and Amazon Music. Search for "MG Show" to listen. Engage with Us Join the conversation on https://t.me/mgshowchannel and participate in live voice chats at https://t.me/MGShow. Social & Support Follow us on X: @intheMatrixxx https://x.com/inthematrixxx @ShadyGrooove https://x.com/shadygrooove Support the show: Fundraiser: https://givesendgo.com/helpmgshow Donate: https://mg.show/support Merch: https://merch.mg.show MyPillow Special: Use code MGSHOW at https://mypillow.com/mgshow for savings! Wanna send crypto? Bitcoin: bc1qtl2mftxzv8cxnzenmpav6t72a95yudtkq9dsuf Ethereum: 0xA11f0d2A68193cC57FAF9787F6Db1d3c98cf0b4D ADA: addr1q9z3urhje7jp2g85m3d4avfegrxapdhp726qpcf7czekeuayrlwx4lrzcfxzvupnlqqjjfl0rw08z0fmgzdk7z4zzgnqujqzsf XLM: GAWJ55N3QFYPFA2IC6HBEQ3OTGJGDG6OMY6RHP4ZIDFJLQPEUS5RAMO7 LTC: ltc1qapwe55ljayyav8hgg2f9dx2y0dxy73u0tya0pu All Links Find everything on https://linktr.ee/mgshow

Send us a textIn this episode of WTR Small-Cap x Healthcare Spotlight crossover episode, we are joined by Lisata Therapeutics' (NASDAQ: LSTA) CEO David Mazzo, PhD and Chief Medical Officer Kristen Buck, MD to talk about, Certepetide, the company's novel solid tumor targeting and penetration technology with tumor microenvironment modifying properties.  We also dive into the recently reported positive preliminary results from Lisata's lead program (Ascend), a Phase 2b study investigating Certepetide for metastatic pancreatic ductal adenocarcinoma (the most common and aggressive form of pancreatic cancer), Lisata's partnerships, and upcoming milestones.  

Die Politologin und Expertin für transatlantische Beziehungen analysiert im Podcast die politische Lage in den USA und sieht die Demokratie in einer kritischen Phase.

Let's talk about Liberation Day — and more importantly, how it's going to end. Back in April, Trump rolled out what looked like a trade war on steroids: a flurry of tariffs aimed at countries big and small, with no clear structure except for one thing — disruption. It was pitched as a three-pronged strategy. First, if you want to sell into the U.S., we should be able to sell into your markets too. Second, we need to re-onshore American manufacturing. And third — and let's be honest, this was the loudest part — Trump wins.For a minute, it wasn't clear whether this was a real attempt to fundamentally restructure trade or just a way to set the stage for a bunch of “deals” later. The tariffs went out, the clock started, and everyone was told they had until August to make a deal or face serious costs. And yet, here we are in mid-July with just two completed agreements: Vietnam and the UK. None of the big players — China, the EU, Japan, Canada, Mexico — are done. So the question becomes, what's the endgame?Here's what I've been told: the White House is prepping a three-phase process that's all about creating the appearance of momentum. Phase one is joint statements — political handshake documents, not legally binding deals. These are meant to say, “Hey, we're working on it, don't hit us with the tariffs yet.” It's what they did with the UK, and it's what they want from everyone else by early August. These aren't trade agreements. They're vibes.Phase two is an interim agreement — maybe 40 to 50 pages, with some of the real trade language baked in. This is where you'll start seeing things like rules of origin pop up — basically, making sure countries like China can't skirt tariffs by routing goods through friendlier ports. It's technical, it's dry, and it takes time, but it's a necessary step toward real enforcement.And phase three, the big one, comes way down the road — probably after the midterms. These are the actual full trade agreements, hundreds of pages long, with all the boring but essential rules locked in. But here's the twist: if you think countries will bother going through phase two and three after they've already locked in the tariff rate during phase one, you're missing the enforcement tool — Section 232. The White House is making it clear: if you slack off, we'll start making noise. We'll investigate. We'll embarrass you. Think Mexican tomatoes — everybody knows they're breaking the rules, and we've just been letting it slide. But not anymore.So when all these joint agreements start rolling out at the end of this month, remember what they are: theater. The deals are political stunts to buy time, stabilize markets, and let Trump declare victory. The real work — the real meat — comes later. And that's how Liberation Day ends. Not with a bang, but with a bunch of bullet-pointed PDFs.Chapters00:00:00 - Intro00:03:05 - How does Liberation Day end?00:16:24 - Interview with Jack Gamble00:41:30 - Update00:41:46 - Epstein Discharge Petition00:50:44 - Virginia Polls00:52:18 - Rescissions Package Passage00:53:36 - Interview with Jack Gamble (con't)01:15:25 - Wrap-up This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.politicspoliticspolitics.com/subscribe

Spencer Herrick, Principal AI Product Manager of Asana and Oliver Myers of AWS demonstrate how their integration allows Asana's AI workflows to access enterprise data from Amazon Q Business, enabling seamless cross-application automation and insights.Topics Include:Oliver Myers leads Amazon Q Business go-to-market, Spencer Herrick manages Asana AI products.Session focuses on end user productivity challenges with generative AI technology implementations.End users face technology overload with doubled workplace application usage over five years.Data silos prevent getting maximum value from generative AI across fragmented enterprise systems.Workers spend 53% of time on "work about work" instead of strategic contributions.Ideal experience needs single pane of glass with cross-application insights and actions.Amazon Q Business launched as managed service with 40+ enterprise data connectors.Connectors maintain end-user permissions from source systems for enterprise security compliance.QIndex feature enables ISVs to access Q Business data via API calls.End users get answers enriched with multiple data sources without switching applications.Asana's work graph connects all tasks, projects, and portfolios to company goals.Phase 1 AI focused on narrow solutions like smart status updates.Phase 2 aimed for AI teammate capabilities requiring extensive contextual knowledge.AI Studio launched as no-code workflow automation builder within Asana platform.Q integration allows AI Studio to access cross-application context beyond Asana boundaries.SmartChat enhanced with Q can answer "what should I work on today?" holistically.Users returning from PTO can quickly understand goal risks across data sources.AI Studio workflows automate feature request processing across Asana, Drive, Slack, email.Partnership eliminates silos while maintaining enterprise security and permission controls.Integration creates connected ecosystem enabling true cross-application AI automation and insights.Participants:Spencer Herrick - Principal AI Product Manager, AsanaOliver Myers - Worldwide Head of Business Development, Amazon Web ServicesFurther Links:Asana.comAsana on AWS MarketplaceSee how Amazon Web Services gives you the freedom to migrate, innovate, and scale your software company at https://aws.amazon.com/isv/

Running back-to-back launches without a strategic timeline is the fastest way to burn out your audience, exhaust your creativity, and watch your conversion rates plummet. In today's episode, I'm breaking down my proven 3 phase campaign timeline that transforms chaotic launches into strategic, story-driven experiences that feel exclusive and exciting every single time. Whether you're launching for the first time or you've been running campaigns back-to-back and feeling the creative burnout, this framework will revolutionize how you approach your next launch. You'll discover the critical re-engagement phase that most people skip (and why it's costing them sales). We'll also chat about how I structure my pre-launch to guide people through personal story, audience re-education, and my unique genius. Plus, the "creative ammo" strategy that turns my launch week into my most inventive period instead of my most stressful. I'm revealing why your audience gets "highly trained" to ignore your campaigns and exactly how to break that pattern. I've used this exact framework to build my seven-figure design agency, and now I'm sharing every detail with you. In today's episode, we're chatting about: • My three-phase campaign framework  • Why exclusivity is everything  • My pre-launch storytelling sequence  • Creative ammo strategy  Connect with me:  Website Join our email list! Instagram Pinterest   Get creative support to turn your content into sales before, during and after your launches. From content classes to learn new campaign marketing skills, to custom designed assets completely done for you, we've thought of it all inside Sales Studio. Join today: https://highflierpowerhouse.com/retainer  Get the photoshoot, website, and content strategy you need to increase your business revenue and reputation. Apply for The Rebrand Experience https://highflierpowerhouse.com/rebrand-experience  

This podcast episode is designed to offer listeners a discussion about the FDA's evolving stance on animal testing and exploring thoughts on its potential phase-out for monoclonal antibody (mAb) therapies. Hosted by Zac Lloyd and featuring expert insights from Dr. Whitney Helms, Executive Director of Nonclinical Development, Large Molecule Discovery at Eli Lilly and Company, and Dr. Diann Blanset, consultant at Akkeri, Inc., this roundtable-style discussion unpacks the scientific, ethical, and regulatory implications of this paradigm shift. Whether you're deep in the biologics pipeline or navigating the changing CRO landscape, this episode offers valuable perspectives on what the future may hold—and how to prepare for it.

Phase 5 of the MCU has come to an end and we ponder the future as we review Ironheart! We discuss mixing magic with technology, the long awaited arrival of Mephisto, and what was up with the marketing and release schedule??Don't forget to rate, comment, share and follow to be notified of all the latest videos from All Things Super!Subscribe: https://tinyurl.com/vodsATSListen: https://tinyurl.com/PodATSFollow #AllThingsSuper: https://linktr.ee/allthingssuper

Here's your local news for Wednesday, July 16, 2025:We detail the history behind a controversial proposal that dominated yesterday's city council meeting,Get some safety recommendations from local public health officials, following the recent spike in drug overdoses,Investigate online rental scams,Learn how an independent journalist is covering immigration issues in Baltimore,Broadcast the most comprehensive weather report on the airwaves,Travel back in time to 1969,And much more.

Thank you SO MUCH to those of you who have joined in for the extra content that is only for Patreon supporters. To get in on the action and support the show with a minor financial contribution just click the link below to sign up. Join up via Patreon at patreon.com/KFSHOW ======================================== Presented with Holley - Back for 2025! Phase 3 of Kibbe and Friends is officially here, and Holley is back for more fun, foolishness, and flying orange Chargers! Once again we're proud to be associated with the historic name that has made cars fast for years and years, and their innovations continue forward (as always)! Make sure that you visit Holley.com to place your speed parts orders - and THANK THEM for continuing on as the Title Sponsor of the KF Show! ======================================== Ron Francis Wiring Brings you the Celebrity Automotive Birthday! https://www.ronfrancis.com ======================================== Dallas Kibbe Racing Update! To follow Dallas Kibbe Racing you can watch his stats and other racing information here. Check it out! https://www.facebook.com/DallasKibbeRacing https://www.instagram.com/dallaskibbe_13/ https://www.tiktok.com/@dallaskibbe_13 MyRacePass.com/drivers/178661. ======================================== Dukes Review: I thought this was an episode with, by, and starring Cleetus in his debut in the Dukes of hazard. It is, it isn't, and it isn't in that order. Cleetus Hogg is introduced to us all in this Season 1 Dukes episode to play the role of Boss Hogg's second cousin twice removed flunky. He does and he is. But he somehow ends up helping Boss Hogg in a bank heist…..that he was in on before it was conceived. And then he fails at it. And then Bo and Luke save the day…..by doing a literal body snatching swap, only I'm not sure that they meant to. Just like Cleetus said in the S3 Episode The Great Santa Claus Chase, "Can someone come get me; I'm lost!" But, it is a Season 1 Dukes Episode, shot in California with 14” wheels on Chargers, and Al Wyatt stunt driving the General in Full Send mode for the entire. C'est magnifique! Rating: 8 (of 10) Corndogs ======================================== National Parts Depot Presents: Bernie on the News! https://www.npdlink.com. The post K&F Show #334: Key Lime Pie, Jet Skis, and AC/DC; Rick Hurst Tribute Dukes Review: S1E11 “Money to Burn” first appeared on The Muscle Car Place.

In this episode, Senior Research Fellow at Mercatus Center and host of Macro Musings David Beckworth breaks down the rising risks of fiscal dominance—when the Fed prioritizes government solvency over price stability. He explains the historical context of fiscal dominance, the warning signs we're seeing today, and why current debt levels, persistent deficits, and political gridlock are pushing us closer to stage three. Beckworth also dives into the mechanics of stablecoins, the Treasury's issuance strategy, and potential reforms to the Fed's operating system, including balance sheet management and NGDP targeting. He warns that without serious structural change, the Fed's independence and credibility may be at risk. Enjoy! __ Follow David: https://x.com/DavidBeckworth Follow Felix: https://x.com/fejau_inc Follow Forward Guidance: https://twitter.com/ForwardGuidance Follow Blockworks: https://twitter.com/Blockworks_ Forward Guidance Telegram: https://t.me/+CAoZQpC-i6BjYTEx Forward Guidance Newsletter: https://blockworks.co/newsletter/forwardguidance __ Join us at Digital Asset Summit in London October 13-15. Use code FORWARD100 for $100 OFF https://blockworks.co/event/digital-asset-summit-2025-london __ This Forward Guidance episode is brought to you by VanEck. Learn more about the VanEck Semiconductor ETF (SMH): http://vaneck.com/SMHFelix Learn more about the VanEck Fabless Semiconductor ETF (SMHX): vaneck.com/SMHXFelix Echo Protocol is the first Bitcoin liquid re-staking and yield layer on MoveVM. As the second-largest protocol on Aptos by TVL, Echo secures nearly half of the network's bridged assets with ~$270M in aBTC minted. https://www.echo-protocol.xyz/ — Timestamps: (00:00) Intro (01:27) Major Regime Shift (05:00) Last Era of Fiscal Dominance (08:13) Ads (VanEck, Aptos) (09:35) Fiscal Dominance Catalysts (12:29) Phases of Fiscal Dominance (18:37) Can Stablecoins Help? (23:51) Active Treasury Issuance (26:44) Ads (VanEck, Aptos) (28:06) Is the Endgame YCC? (31:29) Crossing the Rubicon (33:23) Fed Monetary Policy Framework (38:18) The Ideal Fed Reaction Function (45:18) Rethinking Forward Guidance (47:52) Balance Sheet Goals (52:13) Realistic to Offload Duration? (54:38) Should We Remove IORB? (01:13) Final Thoughts __ Disclaimer: Nothing said on Forward Guidance is a recommendation to buy or sell securities or tokens. This podcast is for informational purposes only, and any views expressed by anyone on the show are opinions, not financial advice. Hosts and guests may hold positions in the companies, funds, or projects discussed. #Macro #Investing #Markets #ForwardGuidance

Dieting forever isn't the answer - strategy is. In this episode, we break down what nutritional periodization actually is, why fat loss should be a phase, and how cycling between deficit, maintenance, and (potentially) building seasons leads to better results with less burnout.apply for 1-1 coaching apply for free nutrition audit follow me on IG

Today we are doing a deep dive into the first PHASE of the business cycle and an offer's journey from $0 to $200K+ in revenue: Starting your signature offer. It is SO important to consider 8 specific things when designing a signature offer for your business so that you build your business on a foundation that will set you up for success in the long term. Many coaches, personal development providers and business owners are not doing this and then have to go back to this phase of the business journey to re-align and start again - usually with lots of stress, frustration and resentment by this stage. And unfortunately for many they simply quit their business for good. But not you! This episode is for you if you're: Starting a new offer for your business, starting a business for the first time, thinking about pivoting your business, if you're an established business owner but something doesn't feel aligned or right with your current business model, you're thinking about expanding your suite of offers for your business or you now need a new signature offer for your business in order to meet your new business, life or scaleability goals. In fact - I recommend that you all listen to this episode no matter what's happening in your business right now as it's very likely at least 1 of these 8 considerations that I speak to in this episode have not been intentionally considered and therefore should be as soon as possible in order to avoid future issues. Most importantly, you'll learn about creating WORLD CLASS signature offers and an Aligned Business Model for you and your business. Happy listening! Apply for My World Class Program here: www.leticiaringe.com/shesworldclass Take my FREE World Class Training here: www.leticiaringe.com/worldclass Download my FREE Menstrual Magic Journal here: www.leticiaringe.com/menstrualmagicjournal Podcast Show Notes at: www.leticiaringe.com/podcast

Ref.: Pfr. Leo Tanner, Exerzitienleiter, Mitinitiator "Wege erwachsenen Glaubens" (WEG), Jonschwil (Kantons St. Gallen), Schweiz Heilung der Lebensgeschichte Unsere Seelenwunden Gott anvertrauen - inneren Frieden finden Manchmal fühlt sich unsere Seele an wie ein ramponiertes Fahrzeug... Weil die Menschen um uns herum nicht perfekt sind und uns das Leben auch belastende Erfahrungen zumutet, finden sich in jeder Seele Spuren alter Verletzungen. Oft spüren wir sie nicht direkt, sondern zum Beispiel an eingefahrenen Verhaltensmustern, die wir weder ganz zuordnen noch abschütteln können. Diesen verborgenen Wunden versuchen wir in der Lebenshilfe auf die Spur zu kommen. In der Reihe „Frieden finden durch Heilung der Lebensgeschichte betrachtet der erfahrene Exerzitien-Prediger Leo Tanner acht Lebensphasen. Immer wird zuerst Gottes Sicht und Plan für unser Leben dargestellt, dann wird auf mögliche Wunden und ihre Wurzeln hingewiesen. Fragen zur Reflexion helfen, in die eigene Lebensgeschichte zurückzugehen. Dann werden heilende Wege aufgezeigt. Heute geht es in der fünften Phase um die Pubertät. Zu jeder Phase gibt es Heilungsgebete, die Sie von unserer Homepage herunter laden können, aber auch auf der Seite von Pfarrer Leo Tanner www.leotanner.ch finden.

In this episode, Dee Kei and Lu explore the art and science of stereo vs. mono recording, the dangers of over-miking, and why intentionality always beats complexity. From phase alignment to comb filtering, they break down the physics and the philosophy behind capturing big, clean, powerful sounds — using fewer tools and smarter techniques.They discuss multi-mic setups, stereo width tricks, reverb placement, and how small changes in mic distance can make or break your mix. There's plenty of studio wisdom, live sound context, and even some fun talk about perfect pitch, nostalgia, and listening preferences.Whether you're tracking a full drum kit or just trying to get your guitars to sit right, this episode will teach you how to think more clearly, record more intentionally, and get better results by doing less.

It wasn't a phase, mom will go over the life and crimes of teens and young adultsOn March 5, 2001, a typical Monday morning at Santana High School in Santee, California, turned into a nightmare. Fifteen-year-old Charles Andrew Williams walked into a school bathroom with a stolen revolver and opened fire—killing two students and injuring thirteen others.In this episode, we dive deep into the events leading up to the shooting: the red flags, the isolation, and the systems that failed him and everyone around him. We'll look at the life of Andy Williams—what he endured, what he said, and the chilling warnings that went ignored. We'll also examine the aftermath, the trial, and the long-term impact on the school, the survivors, and the community.This case is a haunting reminder of what can happen when cries for help are dismissed as “just a phase.”Listener discretion is advised.Follow us on all social media!Facebook - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/bucketmurd⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Twitter - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twitter.com/TheMurderBucket⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/murdbucket/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok -⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@murderbucketpod⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://murderbucketpod.wordpress.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Asia is suddenly awash in deflation. Japan is now experiencing it. And while not necessarily new for China, the acceleration downward to producer prices hints at deterioration in demand, overseas as well as locally. It's become a big enough change the government in Beijing crucially appears to shifting its own economic focus, a potentially profound worldwide signal. Oh, and Jamie Dimon.Eurodollar University's conversations w/Steve Van Metrehttps://www.eurodollar.universityTwitter: https://twitter.com/JeffSnider_EDU

In this episode of Your Money Your Mission, host Kelly Mould and VP of Mortgage Services, Loren Fellows, offer essential tips for navigating the different phases of homeownership. From first-time buyers, those considering a second home or planning to age in place, the discussion covers key financial and lifestyle considerations and actionable advice to ensure both financial well-being and a home that supports your long-term goals. This episode is a must-listen for anyone looking to navigate homeownership with confidence and clarity no matter what stage they're in. 

Back in Episode #401, we reported promising results from a Phase 2 clinical trial for vidofludimus calcium and its impact on progressive MS. This therapy is being developed by Immunic Therapeutics, and this week, Jason Tardio, Immunic's President and Chief Operating Officer, joins me to share some of the specifics of that clinical trial.    Jason will also shed light on why Immunic believes that vidofludimus calcium goes beyond merely slowing disability, potentially offering vital neuroprotection for MS patients, making it a potential game-changer. We're also sharing the encouraging results from a study that focused on the efficacy of neural stem cell transplantation as a remyelination therapy. We'll tell you about a study in the U.K. that measured disability progression among people with MS five years after undergoing autologous hematopoietic stem cell transplantation (aHSCT). You'll learn about an AI tool that can predict whether someone living with MS is likely to experience progression independent of relapse activity (PIRA) with a high degree of accuracy. We'll tell you where you can catch the International Progressive MS Alliance webcast featuring a panel of experts discussing the future role of digital tools in MS research. We'll explain how one of the less publicized aspects of the One Big Beautiful Bill Act will impact future MS care. And Crush MS is less than two weeks away! We're sharing all the details! We have a lot to talk about! Are you ready for RealTalk MS??! This Week: Encouraging results from a clinical trial for progressive MS.  :22 How a less-publicized aspect of the One Big Beautiful Bill Act will impact future MS patient care 1:18 A study looked at the efficacy of neural stem cell transplantation as a remyelination therapy  4:31 A study in the U.K. analyzed disability progression among people with MS five years after receiving autologous hematopoietic stem cell therapy (aHSCT)   7:42 Can AI accurately predict who will experience progression independent of relapse activity (PIRA)?  10:45 Don't miss the International Progressive MS Alliance webcast featuring experts discussing the future role of digital tools in MS research  12:40 Are you ready to support MS research while spending the afternoon in a Napa Valley vineyard? Get all the details to attend Crush MS  13:45 Jason Tardio, President and Chief Operating Officer of Immunic Therapeutics, discusses the recent Phase 2 clinical trial for vidofludimus calcium as a therapy for progressive MS  15:03 Share this episode  30:03 Have you downloaded the free RealTalk MS app?  30:23 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/411 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com Become an MS Activist https://nationalmssociety.org/advocacy STUDY: Remyelination of Chronic Demyelinated Lesions With Directly Induced Neural Stem Cells https://academic.oup.com/brain/advance-article/doi/10.1093/brain/awaf208/8185601 STUDY: Autologous Haemotopoietic Stem Cell Transplantation in the U.K.: A 20-Year Retrospective Analysis of Activity Haematological Outcomes from the British Society of Blood And Marrow Transplantation and Cellular Therapy https://onlinelibrary.wiley.com/doi/epdf/10.1111/bjh.20199 STUDY: Deep Learning to Predict Progression Independent of Relapse Activity at a First Demyelinating Event https://academic.oup.com/braincomms/article/7/4/fcaf243/8185588 WEBCAST: A Discussion From the International Progressive MS Alliance's Digital Tools Workshop https://msif.org/news/2025/07/08/webcast-digital-tools EVENT: Crush MS https://crushms.org Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 411 Guest: Jason Tardio Privacy Policy

Send us a textIn our latest WTR Small-Cap Spotlight x Healthcare Crossover, Cybin CEO Doug Drysdale joins Water Tower Research's Tim Gerdeman and Senior Analyst Robert Sassoon to discuss the company's non-traditional financing strategy as it continues to advance its development pipeline. Drysdale also probes into data that highlight advantages that distinguish Cybin's lead program CYB003 from other aspiring late-stage novel therapies in the depression treatment landscape  Cybin (NYSE: CYBN) is a late-stage clinical development company focused on developing novel psychedelic-based neuropsychiatric compounds. Its two lead candidates, targeting two of the most pervasive mental health disorders, are psilocin-based CYB003 for Major Depressive Disorder (MDD), currently being dosed in a Phase 3 program, and DMT-based CYB004 for General Anxiety Disorder (GAD) which is wrapping up a Phase 2 study.  

Phase 5 officially came to a close with Ironheart and Thunderbolts this summer. Now it's time to rank those movies. What are your thoughts on phase 5 and how would you rank the 6 films

A major State Department plan for its biggest reorganization in decades is underway. The department laid off more than 1300 employees on Friday, impacting both civil service and Foreign Service employees. In total, the department is looking at a 15% overall cut to its workforce. It says it's now moving on to the final phase of its reorganization plan. Federal News Network's Jory Heckman has more.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Jake Knapp and John Zeratsky are the co-creators of the Design Sprint (the famous five-day product innovation process) and authors of the bestselling book Sprint. After decades of working with over 300 startups in the earliest stages, they discovered that most startups fail not because they can't build, but because they build the wrong thing. The very beginning of a startup is your highest-leverage moment, and most teams waste months or years by skipping a few critical early questions. Jake and John developed the Foundation Sprint to help startups validate ideas and compress months of work into just two days.What you'll learn:1. The step-by-step Foundation Sprint process that compresses three or four months of validation into two days—including templates you can use immediately2. Why differentiation is the #1 predictor of startup success (with the 2x2 framework that you can use with your team)3. The three fundamental questions every founder should answer before writing a line of code4. The “note and vote” technique that eliminates groupthink and gets honest answers from your colleagues5. The seven “magic lenses” for choosing between multiple product ideas6. The biggest mistake engineers make when building with AI tools7. The paradox of speed: why “building nothing first” can get you to product-market fit faster—Brought to you by:Brex—The banking solution for startups: https://www.brex.com/product/business-account?ref_code=bmk_dp_brand1H25_ln_new_fsParagon—Ship every SaaS integration your customers want: https://www.useparagon.com/lennyCoda—The all-in-one collaborative workspace: https://coda.io/lenny—Transcript: https://www.lennysnewsletter.com/p/the-foundation-sprint-jake-knapp-and-john-zeratsky—Where to find Jake Knapp:• X: https://twitter.com/jakek• LinkedIn: https://www.linkedin.com/in/jake-knapp/• Website: https://jakeknapp.com/—Where to find John Zeratsky:• X: https://twitter.com/jazer• LinkedIn: https://www.linkedin.com/in/johnzeratsky/• Website: https://johnzeratsky.com/—In this episode, we cover:(00:00) Introduction to Jake Knapp and John Zeratsky(04:41) Origins of the Design Sprint(11:06) The Foundation Sprint process(14:40) Phase one: The basics(16:57) Case study: Latchet(28:50) Phase two: Differentiation(36:24) The importance of differentiation(40:15) Thoughts on price differentiation(43:37) Case study: Mellow(46:04) Custom differentiators(49:30) The mini manifesto(52:02) Phase three: Approach to the project(54:50) Magic lenses activity(01:02:39) Prototyping and testing(01:10:00) Real-world examples and success stories(01:15:15) Motivation behind The Foundation Sprint(01:17:15) The outcome of the sprint: The founding hypothesis(01:19:28) The Design Sprint(01:28:19) The role of AI in prototyping(01:36:50) Final thoughts and resources—Referenced:• Introducing the Foundation Sprint: From the creators of the Design Sprint: https://www.lennysnewsletter.com/p/introducing-the-foundation-sprint• Making time for what matters | Jake Knapp and John Zeratsky (authors of Sprint and Make Time, co-founders of Character Capital): https://www.lennysnewsletter.com/p/making-time-for-what-matters-jake• Eli Blee-Goldman on LinkedIn: https://www.linkedin.com/in/eli-blee-goldman/• Character Capital: https://www.character.vc/• Character Labs: https://www.character.vc/labs• Etsy: https://www.etsy.com/• Shopify: https://www.shopify.com/• Naming expert shares the process behind creating billion-dollar brand names like Azure, Vercel, Windsurf, Sonos, Blackberry, and Impossible Burger | David Placek (Lexicon Branding): https://www.lennysnewsletter.com/p/naming-expert-david-placek• Sonos: https://www.sonos.com/• Vercel: https://vercel.com/• Windsurf: https://windsurf.com/• April Dunford on product positioning, segmentation, and optimizing your sales process: https://www.lennysnewsletter.com/p/april-dunford-on-product-positioning• Positioning: https://www.lennysnewsletter.com/p/positioning• 10 things we know to be true: https://about.google/company-info/philosophy/• Gandalf: https://en.wikipedia.org/wiki/Gandalf• Frodo: https://en.wikipedia.org/wiki/Frodo_Baggins• Mordor: https://en.wikipedia.org/wiki/Mordor• 35 years of product design wisdom from Apple, Disney, Pinterest, and beyond | Bob Baxley: https://www.lennysnewsletter.com/p/35-years-of-product-design-wisdom-bob-baxley• The Primal Mark: How the Beginning Shapes the End in the Development of Creative Ideas: https://www.gsb.stanford.edu/faculty-research/publications/primal-mark-how-beginning-shapes-end-development-creative-ideas• Base44: https://base44.com/• Solo founder, $80M exit, 6 months: The Base44 bootstrapped startup success story | Maor Shlomo: https://www.lennysnewsletter.com/p/the-base44-bootstrapped-startup-success-story-maor-shlomo• Google Meet: https://meet.google.com/• Blue Bottle Coffee: https://bluebottlecoffee.com• Reclaim: https://reclaim.ai/• The official Foundation Sprint + Design Sprint template: https://www.character.vc/miro-template• Rippling: https://www.rippling.com/• Latchet: https://latchet.com/• Mellow: http://getmellow.com/• AxionOrbital: https://axionorbital.space/—Recommended books:• Sprint: How to Solve Big Problems and Test New Ideas in Just Five Days: https://www.amazon.com/Sprint-audiobook/dp/B019R2DQIY• Make Time: How to Focus on What Matters Every Day: https://www.amazon.com/Make-Time-Focus-Matters-Every/dp/0525572422• Click: How to Make What People Want: https://www.amazon.com/Click-Make-What-People-Want/dp/1668072114Production and marketing by https://penname.co/. For inquiries about sponsoring the podcast, email podcast@lennyrachitsky.com.—Lenny may be an investor in the companies discussed. To hear more, visit www.lennysnewsletter.com

In this episode of the Metabolic Freedom Podcast, Ben Azadi breaks down the 3 essential stages of fat loss—and exactly what to eat at each stage to finally lose stubborn belly fat. From lowering insulin and inflammation in Phase 1, to building lean muscle in Phase 2, and optimizing mitochondrial function with powerful biohacks in Phase 3—Ben delivers a complete roadmap to sustainable fat loss. You'll learn the best fat-burning foods, the power of intermittent fasting, movement tips, and his favorite tools like cold plunges, sauna, and apple cider vinegar. Electrolytes: Redmond Relight-  http:www.ketokampsalt.com  coupon  code is "AZADI" for 10% off Keto Chow-  https://amzn.to/44rGF2d  Ultima -https://amzn.to/4lTXjgU  LMNT - DrinkLMNT.com/KetoKamp  Magnesium: Upgraded Formulas: https://upgradedformulas.com/BENAZADI   BiOptimizers: bioptimizers.com/ketokamp Protein supplements (optional): Kion EAAs – http://www.getkion.com/metabolic  for (20% off) Equip Prime Protein – http://www.equipfoods.com/benazadi  for (20% off) Ben's sauna: https://get.sunlighten.com/ketokamp  Cold plunge brand: plunge.com Use code: KETOKAMP Product: https://paleovalley.com/store?pc=pvpartners&oid=25&affid=68  (ACV Complex) UseCoupon code "ketokamp" for 5% off

We're 10 years old!!! And we’re still reelin’, reminiscing, and replaying the bangers that made our indie hearts beat faster. This week, we’re flashing back to the not so distant past - our Best of 2023 – a year that gave us Assamese jazz-pop, Urdu blues, Punjabi folk, and a Marathi abhanga with a guitar solo that’s soooo good, it deserves its own Aadhaar card. We even celebrated our 300th episode that featured a cult band from the early 2000s, and went gaga over a shoegaze dream pop band from Nepal who put across a strong case that momos from Nepal were the best EVVVAAAAAA! This re-release comes with a fresh intro by Senior Producer Ruchi — whose official review of the episode is just one word: “CHILLS.” So plug in, get comfy, and vibe out to the voices that made 2023 unforgettable. Song List: Zero - Take Me Away (04:32 - 09:32) Sampriti - Xathor (10:07 - 16:02) Sameer Rahat - Tasalli (17:37 - 23:02) Banat - Daachi Waaleya (23:38 - 27:09) Swarupa Ananth - Happy Dance (27:54 - 30:54) Abhanga Repost - Aise Kaise Zhale Bhondu (32:14 - 37:47) Nimisha Shankar - Duniya (39:32 - 42:33) Phosphenes - Are You Gonna Leave Me? (44:14 - 48:18) Come be our friend: Instagram @maedinindia Twitter @maedinindia CREDITS: Host: Mae Instagram: @maemariyam Twitter: @maebemaebe Producer: Shaun Fanthome and Meghna Gulati Sound Edited & Mastered by: Kartik Kulkarni Artwork: Alika Gupta

In his weekly clinical update, Dr. Griffin with Vincent Racaniello note that history is being rewritten for justification of changes in COVID vaccine guidelines including myocarditis incidence and the Great Barrington Declaration ignoring presentations at the April 2025 ACIP, the response by the medical community to these changed guidelines, before Dr. Griffin discusses how vaccination associates with reduced dementia risk before deep diving into recent statistics on measles epidemic, RSV, influenza and SARS-CoV-2 infections the Wasterwater Scan dashboard, a potential new influenza antiviral durg, whether or not the NB.1.8.1 should be included in the fall 2025 vaccines, immunization recommendations for COVID-19 vaccines, where to find PEMGARDA, provides information for Columbia University Irving Medical Center's long COVID treatment center, where to go for answers to your long COVID questions, associaton of remesdivir administration and long-term sequelae and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode FDA to look again at myocarditis risk from mRNA-based COVID-19 jabs in young men (FirstWord PHARMA) Great Barrington Declaration (Great Barrington Declaration) Debunking Herd Immunity: A Review of We Want Them Infected (Global Autoimmune Institute Scientific consensus on the COVID-19 pandemic (LANCET) John Snow, memo vaccines-plus strategy (John Snow Memorandum) This CDC Resignation Should Scare You (Substack: Beyond the Noise) COVID-19–Associated Hospitalizations — COVID-NET, April 2025 Update (CDC: National Center for Immunization and Respiratory Diseases) Leading Medical Professional Societies, Patient Sue HHS, Robert F. Kennedy, Jr. for Unlawful, Unilateral Vaccine Changes (ACP: American College of Physicians) Medical groups sue HHS, Kennedy over COVID vaccine policy changes(CIDRAP) Lower risk of dementia with AS01-adjuvanted vaccination against shingles and respiratory syncytial virus infections (Vaccines) Influenza vaccination reduces dementia risk (Ageing Research Reviews) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) New Mexico announces measles outbreak in a county detention facility(AP News) Weekly measles and rubella monitoring (Government of Canada) Measles vaccine recommendations from NYP (jpg) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Measles (CDC Measles (Rubeola)) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts(ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: clift notes (CDC FluView) Cidara Therapeutics Announces Positive Topline Results from its Phase 2b NAVIGATE Trial Evaluating CD388, a Non-Vaccine Preventative of Seasonal Influenza (CIDARA Therapeutics) Experimental flu drug may protect better than flu vaccines(CIDRAP) FDA-CDC-DOD: 2025-2046 influenza vaccine composition (FDA) RSV: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Readmission Following Respiratory Syncytial Virus Hospitalization among Children

Stealing fruit rollups from a baby@spellboundbrewing #radioshow #beer #craftbeer Co hosts : Good ol Boy Dave and Good ol Gal JulieannaSUDS  Episode – Join us for a flavorful journey as we explore a flight of craft beers from Spellbound Brewing in Mount Holly, New Jersey. From the Possession Pale Ale to the Hypnotic Hops IPA, and the Phase 7 Hazy Double IPA, we dive deep into tasting notes, Suds ratings, and the unique characteristics of each brew. Plus, don't miss the grand finale as we savor their award-winning porter aged on Palo Santo, a true standout that brings rich chocolate flavors and intriguing aromas. Tune in for laughs, insights, and a whole lot of beer talk! We taste and rate the following beer from 1-5: All Beer in this episode from Spellbound Brewing, Mt Holly, NJ7:21Possession Pale Ale brewed with Citra Hops- 5.5% ABV SUDS-311:48Hypnotic Hops IPA – brewed with 6 American Hops – 6.8% ABV SUDS-322:16Phase 7 Hazy Double IPA- dry-hopped with Galaxy, Vic Secret and Citra hops- 8% ABV  SUDS-430:49Porter Aged on Paulo Santo- 6.9% ABV  SUDS-5info@sipssudsandsmokes.comX- @sipssudssmokes IG/FB/Bluesky - @sipssudsandsmokesSips, Suds, & Smokes® is produced by One Tan Hand Productions using the power of beer, whiskey, and golf. Available on Apple Podcasts, YouTube Music, Amazon Music, Pandora, iHeart, and nearly anywhere you can find a podcast.Check out Good ol Boy Dave on 60 Second Reviewshttps://www.instagram.com/goodoleboydave/Enjoying that cool new Outro Music, it's from Woods & Whitehead – Back RoadsDownload your copy here:https://amzn.to/2XblorcThe easiest way to find this award winning podcast on your phone is ask Alexa, Siri or Google, “Play Podcast , Sips, Suds, & Smokes” Credits:TITLE: Maxwell Swing/ FlapperjackPERFORMED BY: Texas GypsiesCOMPOSED BY: Steven R Curry (BMI)PUBLISHED BY: Alliance AudioSparx (BMI)TITLE: Back RoadsPERFORMED BY: Woods & WhiteheadCOMPOSED BY: Terry WhiteheadPUBLISHED BY: Terry WhiteheadCOURTESY OF: Terry WhiteheadPost production services : Pro Podcast SolutionsAdvertising sales: Contact us directlyContent hosting services: Talk Media Network, Audioport, Earshot, Radio4All, PodBeanProducer: Good ol Gal Julieanna & Good ol Boy DaveExecutive Producer: Good ol Boy MikeCraft Beer, Spellbound Brewing, Mount Holly, New Jersey, Possession Pale Ale, Hypnotic Hops Ipa, Phase 7 Hazy Double Ipa, Palo Santo, Beer Tasting, Suds Ratings, Craft Beer Flight, Brewery Visit, Beer Reviews, Beer Enthusiasts, Beer Pairings, Hoppy Beers, Porter Beer, American Pale Ale, Craft Beer Culture, Beer Lovers

Dr. Reedy welcomes Dr. Alexa Altman where she discusses how psychedelics bring the unconscious material into consciousness. She talks about the importance of integration. Dr. Altman's Website: https://www.i-psychedelic.com 1. Single-dose psilocybin (25 mg) with psychological support for MDDJAMA – “Single-Dose Psilocybin Treatment for Major Depressive Disorder” psychiatryonline.org+15sunstonetherapies.com+15pmc.ncbi.nlm.nih.gov+15 Summary: Demonstrated strong antidepressant effects and good tolerability over follow-up. Email: info@hopkinspsychedelic.org 2. One-Year Follow-Up of Psilocybin for Depression Study: Long-term effects of psilocybin therapy for depression Johns Hopkins – “Psilocybin treatment for major depression effective for up to a year” Summary: 67% of participants remained in remission one year post-treatment. 3. MDMA-Assisted Therapy for Severe PTSD Randomized, placebo-controlled MDMA-assisted therapy Nature Medicine – “MDMA-assisted therapy for severe PTSD” Summary: Significant reduction in PTSD symptoms, well‑tolerated in a diverse cohort. Contact (MAPS / Lykos Therapeutics): Email: info@maps.org 4. Psilocybin for Cancer-Related Anxiety & Depression Psilocybin in patients with life-threatening cancer PMC – “High-dose psilocybin produced large decreases in depressed mood and anxiety…” Summary: 80% of participants maintained significant symptom relief at 6 months. Website: heffter.org (contact via site) en.wikipedia.org 1. Johns Hopkins University Center for Psychedelic and Consciousness Research Psilocybin for depression, anxiety, addiction, and end-of-life distress Why it's top-tier: The first major U.S. institution to receive regulatory approval for psychedelic research in modern times.

On this episode of The Hollywood Outsider podcast, LOOK UP! In the sky! It's a bird...it's a plane...it's James Gunn's SUPERMAN! David Corenswet dons the red booty shorts and cape for yet another reinvention of DC's classic flying boy scout as he battles negativity, the memory of Henry Cavill, and Nicholas Hoult's devious Lex Luthor in a massive reinvention of the DC Universe (DCU). Rachel Brosnahan joins in as Lois Lane to round out a stellar cast in James Gunn's attempt to revitalize the superhero genre at the box office. Does it work? Listen and find out! Not only is DC Studios reinventing their entire slate, but the Marvel Cinematic Universe has just wrapped up their entire slate of films and TV shows from Phase 5 as they prepare to launch Phase 6 of the MCU later this month with The Fantastic Four: First Steps. So, what's the verdict? We debate all titles in Phase 5 and what our overall take is on this tumultuous time in Disney and Marvel's history. Also discussed on this week's podcast: AMC Theater ads have officially been added to the trailer reel, pushing start times back even further, so how frustrating is it as an audience member? Scarlett Johansson is now the highest grossing box office star worldwide, does that mean anything in today's environment? What's up next in theaters and streaming, and much more! Click here for more info on our 2026 Alaskan Cruise! Discussed on this episode (0:00 – 18:44) Opening | AMC Theater Ads, Scarlett Johansson's Box Office Record (18:45 – 35:52) Marvel Cinematic Universe aka MCU Phase 5 Review (35:53 – 48:22) Why Did You Say That Word?! | Upcoming Attractions  (48:23 – 1:38:01) SUPERMAN - Review and Spoilercast Click here for more info on our 2026 Alaskan Cruise! Listen to our true crime podcast, Inspired By A True Story, now available in your favorite podcast feed! Please support The Hollywood Outsider and gain immediate access to bonus content, including Patreon exclusive podcast content like our Bad Movie Night by visiting Patreon.com/ TheHollywoodOutsider Be sure to join our Facebook Group Join us on Discord Follow us on X @BuyPopcorn Subscribe on Apple Subscribe on Spotify Subscribe via RSS

Authorities have confirmed at least 120 deaths across six counties, including those of 59 adults and 36 children in Kerr County. 

That “lost” feeling? It's not a problem. It's the process.Today kicks off a special series I've been quietly building behind the scenes for a while now.It's called the CREATE Spiral, and it's a new framework I've developed to help artists understand why we get stuck and how to move forward—gently, without shame, and without needing to have it all figured out.In this first episode, we're talking about the very first phase of the spiral: Curiosity.If you've been in a fog, wondering why nothing's exciting you in the studio anymore…If you've felt disconnected from your work, unsure what you want to paint next…If you've caught yourself saying, “Is this all there is?”—this episode is for you.You'll learn why this phase is not a detour—it's a necessary (and powerful) part of your creative growth. And I'll show you how to move through it in a way that invites clarity, energy, and momentum back into your practice.Your Episode MapMajor moments, minute by minute.[0:00–3:00] – Growth isn't linear—meet the Create Spiral[4:00–6:00] – Fear and uncertainty aren't problems—they're part of the path[7:00–8:00] – Curiosity is your most underrated studio tool[9:20–12:00] – That “blah” feeling? It's a clue, not a dead end[12:00–14:00] – You can't rush clarity—give curiosity room to grow[15:00–16:30] – Follow the tiniest spark—even if it makes no sense (yet)

In this episode of FYI, Chief Futurist, Brett Winton, and Analyst Nemo Marjanovic speak with Alex Zhavoronkov, founder and CEO of Insilico Medicine. Together, they explore the promise of artificial intelligence in transforming the drug discovery process—cutting years off timelines and dramatically reducing costs. Alex shares Insilico's journey from algorithm-first beginnings to a full-stack AI-driven biotech company, highlighting their unique “pan flute” model approach to drug development and the vision of building a “pharmaceutical superintelligence.” The discussion touches on Insilico's clinical progress, including a molecule that recently completed a Phase 2 trial, and how its generative platforms are helping to tackle complex diseases with a focus on longevity.Key Points From This Episode:00:00:00 AI's promise in streamlining the drug discovery process00:03:06 The economics of preclinical development and AI's role in optimization00:04:43 Potential cost and timeline reductions: $2.4B down to $600M, 13 years to 800:07:39 Comparing Insilico's approach to peers like Recursion and AbSci00:10:35 Literature-driven vs. biology-driven models in drug discovery00:13:07 Why a dominant AI platform could reshape biotech industry consolidation00:14:57 Why biologics may be more suited to AI than small molecules00:17:35 Alex Zhavoronkov on founding Insilico and his mission in longevity science00:21:00 From algorithms to real drugs: Insilico's transition to clinical development00:23:15 Managing the pace of AI progress vs. the slow cycle of experimental validation00:27:10 How “pharmaceutical superintelligence” enables prompt-to-drug workflows00:32:26 Validation, trust, and why Insilico runs on both old and frontier models00:39:22 The “pan flute” architecture: stacking specialized models with reinforcement learning00:42:36 Building and training a unified multimodal model for chemistry and biology00:45:32 Public data, clean pipelines, and Insilico's automated validation lab00:50:47 The business model behind Insilico: selling candidates and licensing platforms00:55:12 Why pharma buyers care more about data room quality than pricing01:00:25 On profitability, licensing success, and the dream of a self-sustaining AI biotech01:01:38 Longevity and the search for fundamental mechanisms of aging

Thank you to our lovely sponsors : *⁠SHOPIFY⁠: Sign up for a one-dollar-per-month trial period at ⁠https://www.shopify.com/habitsofagoddess⁠ *FUNCTION HEALTH: The first 1000 get a $100 credit toward their membership. Visit www.functionhealth.com/GODDESS or use gift code GODDESS at sign-up to own your health. *ZOCDOC: Go to https://www.Zocdoc.com/HABITS and download the Zocdoc app for FREE. Then find and book a top-rated doctor today. *⁠BOULEVARD⁠: Right now, Boulevard is offering new customers 10% off your first year subscription when you go to join ⁠https://www.joinblvd.com/habits ⁠and book a demo. *⁠Green Chef⁠: Make this spring your most delicious yet with Green Chef. Head to ⁠https://greenchef.com/50GODDESS⁠ and use code ⁠50GODDESS⁠ to get 50% off your first month, then 20% off for two months with free shipping. *⁠BETTERHELP⁠: Get matched today with a licensed therapist when you visit ⁠https://www.betterhelp.com/habitsofagoddess⁠.  * Follow and connect with me here:  Instagram: ⁠https://www.instagram.com/jasminerasco⁠ and ⁠https://www.instagram.com/habitsofagoddess⁠ Youtube: ⁠https://www.youtube.com/@habitsofagoddess/videos ⁠ *Here's how to support the podcast: ⁠https://buymeacoffee.com/habitofagoddess ⁠ *Book a Goddess Chat session with me: ⁠https://habitofagoddess.com/products/goddess-chat-calls⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

Join the Kyle Seraphin Show LIVE 9:30a ET on Rumble, orfind me on Spotify for video replay: https://KyleSeraphinShow.com__________________________________________________Our Sponsors make this program possible:https://PatriotCoolers.com/collections/kyle-seraphin (PROMO KYLE for 10%)https://MyPatriotSupply.com/KYLE (Last Day of the 4th of July Sale)